SciSparc And Clearmind Partnership Yields 3rd Patent Application For The Treating Of Obesity And Metabolic Syndromes – Clearmind Medicine (OTC:CMNDF), SciSparc (NASDAQ:SPRC)
SciSparc Ltd. SPRC announced that Clearmind Medicine Inc. CMNDF CMND CWY, has filed a provisional patent application related to metabolic syndromes including obesity, regarding the company’s collaboration with Clearmind. The…